Product correctly added to cart.

discount label
Cerdulatinib (PRT062070)
View 3D

Biosynth logo

Cerdulatinib (PRT062070)

CAS: 1369761-01-2

Ref. 3D-UEC76101

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Thursday 2 Jan 2025

Product Information

Name:
Cerdulatinib (PRT062070)
Description:

Cerdulatinib is a small molecule that inhibits the activity of the IL-2 receptor. It has been shown to be active against t-cell lymphomas and other cancers such as prostate cancer, breast cancer, and lung cancer. Cerdulatinib inhibits the transcriptional activation of survivin, an anti-apoptotic protein, which may lead to cell death in some cancers. The mechanism of action of cerdulatinib is not well understood, but it has been shown to inhibit nuclear DNA synthesis by binding to nuclear dna and inhibiting cell lysis. Cerdulatinib also has structural similarities with cyclosporine A (CsA), a drug used for transplant rejection. This drug is being studied as a possible treatment for humans with hematopoietic diseases or organ transplant rejection.br>br>

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
482 g/mol
Formula:
C20H28ClN7O3S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UEC76101 Cerdulatinib (PRT062070)

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".